Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciara C O'Sullivan

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Cancer and Clinical Research|January 5, 2016
Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 InhibitorsCiara C O'Sullivan
Expert Opinion on Pharmacotherapy|June 21, 2016
CDK4/6 inhibitors for the treatment of advanced hormone receptor positive breast cancer and beyond: 2016 updateCiara C O'Sullivan
Cancers|February 13, 2026
Cyclin-Dependent 4/6 Kinase Inhibitors for Treatment of HER2-Positive Breast Cancer: 2026 UpdateCiara C O'Sullivan
Expert Opinion on Biological Therapy|March 28, 2013
Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancerCiara C O'Sullivan, Sandra M Swain
Breast Cancer : Basic and Clinical Research|February 27, 2024
Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic OptionsSarah K Premji, Ciara C O'Sullivan
Oncology (Williston Park, N.Y.)|May 27, 2014
Pertuzumab and its accelerated approval: evolving treatment paradigms and new challenges in the management of HER2-positive breast cancerCiara C O'Sullivan, Roisin M Connolly
Current Breast Cancer Reports|October 7, 2014
Therapeutic Considerations in Treating HER2-Positive Metastatic Breast CancerCiara C O'Sullivan, Karen L Smith
CA: a Cancer Journal for Clinicians|August 20, 2020
Evolving standards of care and new challenges in the management of HER2-positive breast cancerGrace M Choong, Grace D Cullen, Ciara C O'Sullivan
Therapeutic Advances in Medical Oncology|December 14, 2019
The emerging role of CDK4/6i in HER2-positive breast cancerCiara C O'Sullivan, Vera J Suman, Matthew P Goetz
Mayo Clinic Proceedings|June 6, 2018
Updates in the Evaluation and Management of Breast CancerCiara C O'Sullivan, Charles L Loprinzi, Tufia C Haddad
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Cancer and Clinical Research|January 5, 2016
Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 InhibitorsCiara C O'Sullivan
Expert Opinion on Pharmacotherapy|June 21, 2016
CDK4/6 inhibitors for the treatment of advanced hormone receptor positive breast cancer and beyond: 2016 updateCiara C O'Sullivan
Cancers|February 13, 2026
Cyclin-Dependent 4/6 Kinase Inhibitors for Treatment of HER2-Positive Breast Cancer: 2026 UpdateCiara C O'Sullivan
Expert Opinion on Biological Therapy|March 28, 2013
Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancerCiara C O'Sullivan, Sandra M Swain
Breast Cancer : Basic and Clinical Research|February 27, 2024
Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic OptionsSarah K Premji, Ciara C O'Sullivan
Oncology (Williston Park, N.Y.)|May 27, 2014
Pertuzumab and its accelerated approval: evolving treatment paradigms and new challenges in the management of HER2-positive breast cancerCiara C O'Sullivan, Roisin M Connolly
Current Breast Cancer Reports|October 7, 2014
Therapeutic Considerations in Treating HER2-Positive Metastatic Breast CancerCiara C O'Sullivan, Karen L Smith
CA: a Cancer Journal for Clinicians|August 20, 2020
Evolving standards of care and new challenges in the management of HER2-positive breast cancerGrace M Choong, Grace D Cullen, Ciara C O'Sullivan
Therapeutic Advances in Medical Oncology|December 14, 2019
The emerging role of CDK4/6i in HER2-positive breast cancerCiara C O'Sullivan, Vera J Suman, Matthew P Goetz
Mayo Clinic Proceedings|June 6, 2018
Updates in the Evaluation and Management of Breast CancerCiara C O'Sullivan, Charles L Loprinzi, Tufia C Haddad
Pageof 5